Check out our latest webinar, “Safety and Feasibility of a Compensated Donor Model”. Click here to watch!
The STS Solution
STS has modernized the platelet collection model to help address the nation's platelet shortage
Secure Transfusion Solutions (STS) has developed a safe, compensation-based model that can supplement and diversify hospitals’ platelet supplies with 100% pathogen-reduced, single-donor apheresis platelets.
Federal mandates may constrain platelet availability even more4
The safety of platelet transfusions is critical, and the recent US Food and Drug Administration (FDA) mandate requires bacterial risk mitigation strategies such as large volume delayed sampling or pathogen reduction. Processing requirements associated with these bacterial risk mitigation strategies may further erode the platelet supply.